Oral Vaccine Market Report

Global Oral Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 25, 2022
  • PAGES：220
  • REPORT CODE：GMM777661
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oral Vaccine market report explains the definition, types, applications, major countries, and major players of the Oral Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Serum Institute

    • GSK

    • Merck

    • Tiantan Biological

    • Bio-Med

    • Shanghai United Cell

    • Halfkin Bio-Pharmaceuticals

    • Vabiotech

    • PaxVax

    • Valneva

    • Sanofi

    • EuBiologics

    • Bibcol

    • Lanzhou Institute

    • Panacea Biotec Ltd

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oral Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oral Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Oral Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oral Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oral Vaccine Market- Recent Developments

    • 6.1 Oral Vaccine Market News and Developments

    • 6.2 Oral Vaccine Market Deals Landscape

    7 Oral Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Oral Vaccine Key Raw Materials

    • 7.2 Oral Vaccine Price Trend of Key Raw Materials

    • 7.3 Oral Vaccine Key Suppliers of Raw Materials

    • 7.4 Oral Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Oral Vaccine Cost Structure Analysis

      • 7.5.1 Oral Vaccine Raw Materials Analysis

      • 7.5.2 Oral Vaccine Labor Cost Analysis

      • 7.5.3 Oral Vaccine Manufacturing Expenses Analysis

    8 Global Oral Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oral Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oral Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oral Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cholera Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Oral Polio Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Public Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oral Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Oral Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oral Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Oral Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Oral Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oral Vaccine Consumption (2017-2022)

      • 10.3.2 UK Oral Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Oral Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Oral Vaccine Consumption (2017-2022)

      • 10.3.5 France Oral Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Oral Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Oral Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Oral Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Oral Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Oral Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Oral Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Oral Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Oral Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oral Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Oral Vaccine Consumption (2017-2022)

      • 10.4.3 India Oral Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Oral Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Oral Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Oral Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Oral Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Oral Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Oral Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Oral Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Oral Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Oral Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oral Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Oral Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Oral Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Oral Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Oral Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Oral Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oral Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Oral Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oral Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Oral Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Oral Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Oral Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oral Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oral Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oral Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Oral Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Oral Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Oral Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oral Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Oral Vaccine Consumption (2017-2022)

    11 Global Oral Vaccine Competitive Analysis

    • 11.1 Serum Institute

      • 11.1.1 Serum Institute Company Details

      • 11.1.2 Serum Institute Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Serum Institute Oral Vaccine Main Business and Markets Served

      • 11.1.4 Serum Institute Oral Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Oral Vaccine Main Business and Markets Served

      • 11.2.4 GSK Oral Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Merck

      • 11.3.1 Merck Company Details

      • 11.3.2 Merck Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Merck Oral Vaccine Main Business and Markets Served

      • 11.3.4 Merck Oral Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Tiantan Biological

      • 11.4.1 Tiantan Biological Company Details

      • 11.4.2 Tiantan Biological Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Tiantan Biological Oral Vaccine Main Business and Markets Served

      • 11.4.4 Tiantan Biological Oral Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bio-Med

      • 11.5.1 Bio-Med Company Details

      • 11.5.2 Bio-Med Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bio-Med Oral Vaccine Main Business and Markets Served

      • 11.5.4 Bio-Med Oral Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Shanghai United Cell

      • 11.6.1 Shanghai United Cell Company Details

      • 11.6.2 Shanghai United Cell Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Shanghai United Cell Oral Vaccine Main Business and Markets Served

      • 11.6.4 Shanghai United Cell Oral Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Halfkin Bio-Pharmaceuticals

      • 11.7.1 Halfkin Bio-Pharmaceuticals Company Details

      • 11.7.2 Halfkin Bio-Pharmaceuticals Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Main Business and Markets Served

      • 11.7.4 Halfkin Bio-Pharmaceuticals Oral Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Vabiotech

      • 11.8.1 Vabiotech Company Details

      • 11.8.2 Vabiotech Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Vabiotech Oral Vaccine Main Business and Markets Served

      • 11.8.4 Vabiotech Oral Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 PaxVax

      • 11.9.1 PaxVax Company Details

      • 11.9.2 PaxVax Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 PaxVax Oral Vaccine Main Business and Markets Served

      • 11.9.4 PaxVax Oral Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Valneva

      • 11.10.1 Valneva Company Details

      • 11.10.2 Valneva Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Valneva Oral Vaccine Main Business and Markets Served

      • 11.10.4 Valneva Oral Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Sanofi

      • 11.11.1 Sanofi Company Details

      • 11.11.2 Sanofi Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Sanofi Oral Vaccine Main Business and Markets Served

      • 11.11.4 Sanofi Oral Vaccine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 EuBiologics

      • 11.12.1 EuBiologics Company Details

      • 11.12.2 EuBiologics Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 EuBiologics Oral Vaccine Main Business and Markets Served

      • 11.12.4 EuBiologics Oral Vaccine Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Bibcol

      • 11.13.1 Bibcol Company Details

      • 11.13.2 Bibcol Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Bibcol Oral Vaccine Main Business and Markets Served

      • 11.13.4 Bibcol Oral Vaccine Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Lanzhou Institute

      • 11.14.1 Lanzhou Institute Company Details

      • 11.14.2 Lanzhou Institute Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Lanzhou Institute Oral Vaccine Main Business and Markets Served

      • 11.14.4 Lanzhou Institute Oral Vaccine Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Panacea Biotec Ltd

      • 11.15.1 Panacea Biotec Ltd Company Details

      • 11.15.2 Panacea Biotec Ltd Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Panacea Biotec Ltd Oral Vaccine Main Business and Markets Served

      • 11.15.4 Panacea Biotec Ltd Oral Vaccine Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Oral Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Oral Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Oral Polio Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oral Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Public Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Private Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oral Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Oral Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oral Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oral Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oral Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oral Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oral Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oral Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oral Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oral Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oral Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oral Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oral Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oral Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oral Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oral Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oral Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oral Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oral Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oral Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oral Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oral Vaccine

    • Figure of Oral Vaccine Picture

    • Table Global Oral Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oral Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Rotavirus Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Cholera Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Polio Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Public Consumption and Growth Rate (2017-2022)

    • Figure Global Private Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Vaccine Consumption by Country (2017-2022)

    • Table North America Oral Vaccine Consumption by Country (2017-2022)

    • Figure United States Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Vaccine Consumption by Country (2017-2022)

    • Figure Germany Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Oral Vaccine Consumption by Country (2017-2022)

    • Figure China Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Oral Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Oral Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Oral Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Oral Vaccine Consumption by Country (2017-2022)

    • Figure Australia Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oral Vaccine Consumption and Growth Rate (2017-2022)

    • Table Serum Institute Company Details

    • Table Serum Institute Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute Oral Vaccine Main Business and Markets Served

    • Table Serum Institute Oral Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Oral Vaccine Main Business and Markets Served

    • Table GSK Oral Vaccine Product Portfolio

    • Table Merck Company Details

    • Table Merck Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Oral Vaccine Main Business and Markets Served

    • Table Merck Oral Vaccine Product Portfolio

    • Table Tiantan Biological Company Details

    • Table Tiantan Biological Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiantan Biological Oral Vaccine Main Business and Markets Served

    • Table Tiantan Biological Oral Vaccine Product Portfolio

    • Table Bio-Med Company Details

    • Table Bio-Med Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Med Oral Vaccine Main Business and Markets Served

    • Table Bio-Med Oral Vaccine Product Portfolio

    • Table Shanghai United Cell Company Details

    • Table Shanghai United Cell Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai United Cell Oral Vaccine Main Business and Markets Served

    • Table Shanghai United Cell Oral Vaccine Product Portfolio

    • Table Halfkin Bio-Pharmaceuticals Company Details

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccine Main Business and Markets Served

    • Table Halfkin Bio-Pharmaceuticals Oral Vaccine Product Portfolio

    • Table Vabiotech Company Details

    • Table Vabiotech Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vabiotech Oral Vaccine Main Business and Markets Served

    • Table Vabiotech Oral Vaccine Product Portfolio

    • Table PaxVax Company Details

    • Table PaxVax Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table PaxVax Oral Vaccine Main Business and Markets Served

    • Table PaxVax Oral Vaccine Product Portfolio

    • Table Valneva Company Details

    • Table Valneva Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valneva Oral Vaccine Main Business and Markets Served

    • Table Valneva Oral Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Oral Vaccine Main Business and Markets Served

    • Table Sanofi Oral Vaccine Product Portfolio

    • Table EuBiologics Company Details

    • Table EuBiologics Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table EuBiologics Oral Vaccine Main Business and Markets Served

    • Table EuBiologics Oral Vaccine Product Portfolio

    • Table Bibcol Company Details

    • Table Bibcol Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bibcol Oral Vaccine Main Business and Markets Served

    • Table Bibcol Oral Vaccine Product Portfolio

    • Table Lanzhou Institute Company Details

    • Table Lanzhou Institute Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lanzhou Institute Oral Vaccine Main Business and Markets Served

    • Table Lanzhou Institute Oral Vaccine Product Portfolio

    • Table Panacea Biotec Ltd Company Details

    • Table Panacea Biotec Ltd Oral Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Biotec Ltd Oral Vaccine Main Business and Markets Served

    • Table Panacea Biotec Ltd Oral Vaccine Product Portfolio

    • Figure Global Rotavirus Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cholera Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Polio Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Public Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oral Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oral Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US